| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.7M | -27.0% |
| Cost of Revenue | $11.3M | -1.1% |
| R&D Expense | $2.1M | -55.2% |
| SG&A Expense | $18.4M | +30.3% |
| Operating Income | -$21.3M | -53.2% |
| Interest Expense | $6.1M | +163.1% |
| Pre-tax Income | -$55.5M | -301.9% |
| Income Tax | -$9K | -200.0% |
| Net Income | -$55.5M | -302.0% |
| EPS (Basic) | -$5.22 | -2033.3% |
| EPS (Diluted) | -$5.22 | -2033.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52K | -99.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $3.1M | -69.9% |
| Inventory | $308K | -77.1% |
| Current Assets | $12.3M | -83.5% |
| Total Assets | $14.4M | -80.9% |
| Current Liabilities | $34.8M | -21.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.6M | +17.6% |
| Capital Expenditures | $448K | +100.9% |
| Investing Cash Flow | $4.8M | +129.7% |
| Financing Cash Flow | -$2.3M | -107.5% |
| Free Cash Flow | -$17.1M | +16.3% |
| Total Liabilities |
| $34.9M |
| -21.6% |
| Stockholders' Equity | -$20.4M | -165.8% |